Margarida Maria Videira Henriques

Margarida Maria Videira Henriques

Auto-generated profile, based on publicly available information

Margarida Maria Videira Henriques

Centro Hospitalar de Leiria (CHL), Leiria, Portugal

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
PDF file
PMPatrícia Sofia Ferreira Miranda
Patrícia Sofia Ferreira Miranda
EPEster Preciosa Maio Nunes Pereira
Ester Preciosa Maio Nunes Pereira
JBJoana Serra Caetano Baltazar Barreto
Joana Serra Caetano Baltazar Barreto
MHMargarida Maria Videira Henriques
Margarida Maria Videira Henriques
MMMaria Alice Santos Cordeiro Mirante
Maria Alice Santos Cordeiro Mirante
LRLina Maria Jesus Ferreira Cardoso Ramos
Lina Maria Jesus Ferreira Cardoso Ramos
Objective: To present a case of bilateral gynecomastia in a prepubertal boy with autism spectrum disorder, diagnosed with myotonic dystrophy type 1. Case description: A 12-year-old boy with autism spectrum disorder presented at a follow-up visit with bilateral breast growth. There was a family history of gynecomastia, cataracts at a young age, puberty delay, and myotonic dystrophy type 1. The physical examination showed that he had bilateral gynecomastia with external genitalia Tanner stage 1. Neurologic examination was regular, without demonstrable myotonia. The analytical study revealed increased estradiol levels and estradiol/testosterone ratio. After excluding endocrine diseases, the molecular study of the dystrophia myotonica protein kinase gene confirmed the diagnosis of myotonic dystrophy type 1. Comments: A diagnosis of prepubertal gynecomastia should include an investigation for possible underlying diseases. This case report highlights the importance of considering the diagnosis of myotonic dystrophy type 1 in the presence of endocrine and neurodevelopmental manifestations.

4 February 2021 in Scientia Medica
Verified
Journal Article
Open access
PDF file
CFCarla Andreia Esteves Fernandes
Carla Andreia Esteves Fernandes
ACAna Francisca Henriques Cardoso
Ana Francisca Henriques Cardoso
CLCaroline Reis Lopes
Caroline Reis Lopes
MHMargarida Maria Videira Henriques
Margarida Maria Videira Henriques
EPEster Preciosa Maio Nunes Pereira
Ester Preciosa Maio Nunes Pereira
AIMS: The aims of this study were to characterize the etiological investigation of genetic cause in the autism spectrum disorder and to determine the factors related to its identification.METHODS: A retrospective descriptive study, with an analytical component, included children and adolescents with autism spectrum disorder followed in consultation at a level 2 hospital, between November 2017 and October 2019. The following variables were analyzed: age, sex, age at the first consultation, family history, objective examination, cognitive assessment, etiological investigation of genetic cause and etiological diagnosis of genetic cause. Statistical analysis was performed using the SPSS®v23 program (significance level 0.05).RESULTS: We identified 153 children with autism spectrum disorder, of which 48 underwent a genetic cause investigation: 45 performed microarray analysis (15.6% pathogenic); 42 carried out a molecular study of the Fragile X syndrome (one altered); two performed sequencing of the methyl CpG binding protein 2 (MECP2) gene (one altered). The diagnosis of genetic cause was made in 18.8% of the sample. The identification of the etiology of a genetic cause was related to global development delay/ intellectual disability (p = 0.04) and the presence of relevant family history (p = 0.005).CONCLUSIONS: The diagnostic yield of the genetic study was higher in patients with a global development delay /intellectual disability and in patients with relevant family history.